Maselli, D. J., Rogers, L., & Peters, J. I. (2018). Benralizumab, an add-on treatment for severe eosinophilic asthma: Evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use. Ther Clin Risk Manag.
Chicago-stil citatMaselli, Diego Jose, Linda Rogers, och Jay I. Peters. "Benralizumab, an Add-on Treatment for Severe Eosinophilic Asthma: Evaluation of Exacerbations, Emergency Department Visits, Lung Function, and Oral Corticosteroid Use." Ther Clin Risk Manag 2018.
MLA-referensMaselli, Diego Jose, Linda Rogers, och Jay I. Peters. "Benralizumab, an Add-on Treatment for Severe Eosinophilic Asthma: Evaluation of Exacerbations, Emergency Department Visits, Lung Function, and Oral Corticosteroid Use." Ther Clin Risk Manag 2018.